Valuation: Stryker Corporation

Market Cap 106B 1,822B 92.02B 86.89B 78.9B 148B 10,126B 148B 1,041B 402B 5,148B 396B 388B 16,565B P/E 2026 *
21.4x
P/E 2027 * 18.6x
Enterprise Value 115B 1,979B 99.98B 94.4B 85.72B 161B 11,002B 161B 1,131B 436B 5,593B 431B 421B 17,997B EV / Sales 2026 *
4.21x
EV / Sales 2027 * 3.76x
Free-Float
94.9%
Yield 2026 *
1.31%
Yield 2027 * 1.39%
1 day+1.22%
1 week+1.22%
Current month-13.29%
1 month-16.93%
3 months-9.04%
6 months-22.69%
Current year-24.56%
1 week 4,828
Extreme 4828
4,828
1 month 4,770
Extreme 4770
5,568.24
Current year 4,770
Extreme 4770
6,769.22
1 year 4,770
Extreme 4770
6,982
3 years 4,663.01
Extreme 4663.01
8,216
5 years 3,953.6
Extreme 3953.6
8,216
10 years 2,469
Extreme 2469
8,216
Manager TitleAgeSince
Chief Executive Officer 60 2012-09-30
President 49 2025-12-31
Director of Finance/CFO 50 2025-03-31
Director TitleAgeSince
Director/Board Member 82 1973-12-31
Director/Board Member 71 1983-12-31
Chairman 60 2014-07-21
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%+1.22% - - 106B
-1.79%-0.16%-27.19%-6.17% 106B
-0.77%+1.88%-24.84%-2.00% 11.56B
+1.48%-2.06%+90.83%+116.88% 9.66B
+0.75%+2.06%-52.06%-71.12% 4.02B
+0.39%+0.36%-28.86%+21.76% 2.34B
+5.55%+5.18%-7.94%-63.46% 2.22B
+4.97%+4.82% - - 1.93B
+0.72%+1.95%-20.50%-29.27% 1.53B
Average +1.39%+1.47%-10.08%-4.77% 17.35B
Weighted average by Cap. -0.11%+0.08%-19.03%+0.24%

Financials

2026 *2027 *
Net sales 27.25B 470B 23.76B 22.44B 20.38B 38.18B 2,615B 38.34B 269B 104B 1,330B 102B 100B 4,278B 29.63B 511B 25.84B 24.4B 22.15B 41.51B 2,843B 41.68B 292B 113B 1,445B 111B 109B 4,651B
Net income 4.94B 85.32B 4.31B 4.07B 3.7B 6.92B 474B 6.95B 48.74B 18.81B 241B 18.56B 18.15B 776B 5.75B 99.19B 5.01B 4.73B 4.3B 8.05B 551B 8.08B 56.67B 21.87B 280B 21.58B 21.1B 902B
Net Debt 9.13B 158B 7.96B 7.51B 6.82B 12.78B 876B 12.84B 90B 34.73B 445B 34.28B 33.52B 1,432B 5.89B 102B 5.14B 4.85B 4.41B 8.25B 565B 8.29B 58.12B 22.43B 287B 22.14B 21.64B 925B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
275.12USD
Average target price
374.28USD
Spread / Average Target
+36.04%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!